Medtronic gains FDA OK for stent graft, introducer sheath

05/31/2013 | CardiovascularBusiness.com

Medtronic has gained FDA approval for its Endurant II Aorto-Uni-Iliac Stent Graft, designed to treat abdominal aortic or aorto-iliac aneurysm patients who cannot be treated with a bifurcated device. The firm also earned 510(k) clearance for its Sentrant Introducer Sheath, which allows passage of stent grafts from the access site in the femoral artery to the therapy site.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT